Delivery Order SPE2DB22D2206-SPE2DB24FHC07
Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $6,593.82 Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets. This contract has a period of performance through September 19, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support DLA Troop Support Medical's mission of supplying medical commodities to military treatment facilities and other government...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,915.95 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,221.93 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. The contract has an ultimate completion date of September 23, 2024 and does not utilize a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,088.15 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets in 30-count packages, with a completion date of February 28, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,584.15, is for the delivery of Telmisartan 80 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $15,123.75 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Telmisartan-HCTZ 80-25 mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,065.92 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a hypertension medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite...
- The Defense Logistics Agency (DLA) awarded a $14,041.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a...
- The Defense Logistics Agency awarded a $1,194.39 firm fixed price delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency (DLA) awarded a $1,105.65 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets, and has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHC07Delivery Order
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,694.68 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.
Generated 5/16/25, 12:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/8/24 |